Results 141 to 150 of about 25,739 (194)

Isoindolines and Isoindoline-1,3-diones as Nonpeptide ACE Inhibitors: An <i>In Silico</i> and <i>In Vitro</i> Modeling Approach. [PDF]

ACS Med Chem Lett
Rodríguez JE, Lagos-Cruz JA, Villalobos-Molina R, Cuevas-Hernández RI, Gallardo-Ortíz IA, Andrade-Jorge E.   +5 more
europepmc   +1 more source

Successful Living Kidney Donation from Heterozygous Carrier Parents to Siblings with Coenzyme Q8B Nephropathy: Two Case Series. [PDF]

Nephron
Morita K, Nakanishi R, Ogura K, Shinzato T, Matsuo K, Tanaka S, Matsumoto M, Yamamoto S, Kitayama H, Nagano C, Nozu K, Nagai K.   +11 more
europepmc   +1 more source

Effect of tranexamic acid in the treatment of angiotensin-converting enzyme inhibitor-induced angioedema: A systematic review and meta-analysis. [PDF]

Turk J Emerg Med
Couppoussamy KI, Mahalingam S, Rajendran G, Purushothaman S, Ramkumar A, Krishnamoorthy Y, Ganessane E, Kumaran A.   +7 more
europepmc   +1 more source

A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules. [PDF]

CPT Pharmacometrics Syst Pharmacol
Posada MM, Schneck KB, Morse BL, Rougee LRA, Tham LS, Rehmel JF, Thompson B, Stamatis SD, Hall SD, Dickinson GL.   +9 more
europepmc   +1 more source

Reversing the irreversible? A case of successful surgical repair in a late-presenting aortopulmonary window with severe pulmonary hypertension. [PDF]

Egypt Heart J
Mulawarman R, Ongko Joyo E, Aefiansyah Putra MA, Agita Sembiring A, Natalia Siagian S, Lilyasari O.   +5 more
europepmc   +1 more source

Post-market quality monitoring of medicines in Christian Health Association of Ghana health institutions. [PDF]

Ghana Med J
Arhinful DK, Yeboah P, Duah J, Antwi MA, Attachey A, Karikari-Boateng E, Awal AM, Rinke de Wit TF, Kretchy IA.   +8 more
europepmc   +1 more source

Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET^® in Japan. [PDF]

Hypertens Res
Kinoshita Y, Ando T, Kajiyama K, Maruyama H, Kohama M, Tanaka A, Matsunaga Y, Ishiguro C, Nonaka T, Horiuchi N, Tanaka T, Uyama Y.   +11 more
europepmc   +1 more source

A Dose-Aware Model for Revealing Dose-Risk Relationship of Drug-Drug Interaction. [PDF]

CPT Pharmacometrics Syst Pharmacol
Shi Y, Sun A, Yang Y, Nan H, Xu J, Shan M, Eadon MT, Su J, Zhang P.   +8 more
europepmc   +1 more source

Recessive variants in the intergenic NOS1AP-C1orf226 locus cause monogenic kidney disease responsive to anti-proteinuric treatment. [PDF]

Nat Commun
Buerger F, Salmanullah D, Liang L, Gauntner V, Krueger K, Qi J, Normand J, Sharma V, Ranga A, Rubin A, Ball D, Hong S, Lemberg K, Saida K, Merz LM, Sever S, Issac B, Ma Q, Sun L, Billing AM, Demir F, Rinschen MM, Reusch B, Beck BB, Guerrero-Castillo S, Nephrotic Syndrome Study Network (NEPTUNE), Gomez AC, McNulty MT, Sampson MG, Al-Hamed MH, Saleh MM, Shalaby MA, Kari JA, Fawcett JP, Hildebrandt F, Majmundar AJ.   +35 more
europepmc   +1 more source